IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v404y2000i6773d10.1038_35003583.html
   My bibliography  Save this article

Cannabinoids control spasticity and tremor in a multiple sclerosis model

Author

Listed:
  • David Baker

    (Neuroinflammation Group, Institute of Neurology, University College London
    Institute of Ophthalmology, UCL)

  • Gareth Pryce

    (Neuroinflammation Group, Institute of Neurology, University College London
    Institute of Ophthalmology, UCL)

  • J. Ludovic Croxford

    (Neuroinflammation Group, Institute of Neurology, University College London
    Institute of Ophthalmology, UCL)

  • Peter Brown

    (The Medical Research Council Human Movement and Balance Unit, National Hospital for Neurology and Neurosurgery)

  • Roger G. Pertwee

    (University of Aberdeen)

  • John W. Huffman

    (Clemson University)

  • Lorna Layward

    (Multiple Sclerosis Society of Great Britain and Northern Ireland)

Abstract

Chronic relapsing experimental allergic encephalomyelitis (CREAE) is an autoimmune model of multiple sclerosis1. Although both these diseases are typified by relapsing-remitting paralytic episodes, after CREAE induction by sensitization to myelin antigens1 Biozzi ABH mice also develop spasticity and tremor. These symptoms also occur during multiple sclerosis and are difficult to control. This has prompted some patients to find alternative medicines, and to perceive benefit from cannabis use2. Although this benefit has been backed up by small clinical studies, mainly with non-quantifiable outcomes3,4,5,6,7, the value of cannabis use in multiple sclerosis remains anecdotal. Here we show that cannabinoid (CB) receptor agonism using R(+)-WIN 55,212, Δ9-tetrahydrocannabinol, methanandamide and JWH-133 (ref. 8) quantitatively ameliorated both tremor and spasticity in diseased mice. The exacerbation of these signs after antagonism of the CB1 and CB2 receptors, notably the CB1 receptor, using SR141716A and SR144528 (ref. 8) indicate that the endogenous cannabinoid system may be tonically active in the control of tremor and spasticity. This provides a rationale for patients' indications of the therapeutic potential of cannabis in the control of the symptoms of multiple sclerosis2, and provides a means of evaluating more selective cannabinoids in the future.

Suggested Citation

  • David Baker & Gareth Pryce & J. Ludovic Croxford & Peter Brown & Roger G. Pertwee & John W. Huffman & Lorna Layward, 2000. "Cannabinoids control spasticity and tremor in a multiple sclerosis model," Nature, Nature, vol. 404(6773), pages 84-87, March.
    • Handle: RePEc:nat:nature:v:404:y:2000:i:6773:d:10.1038_35003583
    DOI: 10.1038/35003583
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/35003583
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/35003583?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Alessandro Enrico Grimaldi & Laura De Giglio & Shalom Haggiag & Assunta Bianco & Antonio Cortese & Sebastiano Giuseppe Crisafulli & Fabrizia Monteleone & Gerola Marfia & Luca Prosperini & Simonetta Ga, 2019. "The influence of physiotherapy intervention on patients with multiple sclerosis–related spasticity treated with nabiximols (THC:CBD oromucosal spray)," PLOS ONE, Public Library of Science, vol. 14(7), pages 1-10, July.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:404:y:2000:i:6773:d:10.1038_35003583. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.